Evidence map›Paper›PMID 28223445›Full record

ReviewDiabetes care2017

Diabetic Retinopathy: A Position Statement by the American Diabetes Association.

Sharon D Solomon, Emily Chew, Elia J Duh, Lucia Sobrin, Jennifer K Sun, Brian L VanderBeek, Charles C Wykoff, Thomas W Gardner

Erratum issued Registry-linked trialAbstract readReview
In one paragraph

Review in Diabetes care, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to trial NCT07351786 (Impact of the New Generation Anti-diabetic Drugs on Diabetic Retinopathy), which is not on this map. Cited by 481 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
481citing papers in PubMed, 5 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07351786 recruitingnot on this mapstarted 2025, after this paper: background citation

Impact of the New Generation Anti-diabetic Drugs on Diabetic Retinopathy

TypeobservationalSponsorSara A BelalRan2025 to 2026Enrolled70ConditionsDiabetes (DM), Retinopathy, Diabetic, Diabetic Retinopathy (DR), Diabetic Retinopathy Associated With Type 2 Diabetes Mellitus
3 · Its place in the literature

Who cites it

481 citing papers in PubMed, 5 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Trial
  8. Article
  9. Article
  10. Article
  11. Article
  12. Neuroprotection in Early Diabetic Retinal Disease Using Eyedrop Delivery.International journal of molecular sciences · 2026
    Review
  13. Article
  14. Article
  15. Knowledge of Interpreter Rights and Medication Delays in Diabetes Care.Journal of immigrant and minority health · 2026
    Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article

421 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Sharon D SolomonWilmer Eye Institute, Johns Hopkins Medicine, Baltimore, MD.
Emily ChewNational Eye Institute, National Institutes of Health, Bethesda, MD.
Elia J DuhWilmer Eye Institute, Johns Hopkins Medicine, Baltimore, MD.
Lucia SobrinDepartment of Ophthalmology, Massachusetts Eye and Ear Infirmary, Boston, MA.
Jennifer K SunBeetham Eye Institute, Joslin Diabetes Center, Boston, MA.
Brian L VanderBeekDepartment of Ophthalmology, University of Pennsylvania, Philadelphia, PA.
Charles C WykoffRetina Consultants of Houston, Houston, TX.
Thomas W GardnerDepartment of Ophthalmology and Visual Sciences, Kellogg Eye Center, University of Michigan, Ann Arbor, MI tomwgard@umich.edu.

Funding

Patient Centered Care for Diabetic Macular EdemaK23EY025729 · NEI · UNIVERSITY OF PENNSYLVANIA · PI VANDERBEEK, BRIAN L. · 2015 to 2019
$1.1M
NEI NIH HHS K23 EY025729NEI NIH HHS L30 EY023819
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID28223445
PMCPMC5402875

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.